Jillion Therapeutics Inc.
Jillion Therapeutics is an early-stage biotech company developing novel small-molecule medicines for CNS disorders. They pursue mechanism-driven drug discovery by targeting underexplored brain pathways to treat conditions with few effective options. Core tech includes chemistry, neuroscience, High-Power Screening (HPS), and AI/ML to accelerate hit and lead optimization. Their platform uses proprietary and licensed methods to rapidly generate CNS drug leads, with potential relevance to oncology and metabolic diseases. The company collaborates toward pharma and biotech partners in the drug discovery space.
Jillion Therapeutics Inc.
Jillion Therapeutics is an early-stage biotech company developing novel small-molecule medicines for CNS disorders. They pursue mechanism-driven drug discovery by targeting underexplored brain pathways to treat conditions with few effective options. Core tech includes chemistry, neuroscience, High-Power Screening (HPS), and AI/ML to accelerate hit and lead optimization. Their platform uses proprietary and licensed methods to rapidly generate CNS drug leads, with potential relevance to oncology and metabolic diseases. The company collaborates toward pharma and biotech partners in the drug discovery space.